rs756952430

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4BP6_Very_StrongBS2

The NM_020822.3(KCNT1):​c.626G>A​(p.Arg209His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,455,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R209C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000016 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KCNT1
NM_020822.3 missense

Scores

1
4
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 3.24

Publications

2 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.41640145).
BP6
Variant 9-135757181-G-A is Benign according to our data. Variant chr9-135757181-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 574245.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 24 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.626G>Ap.Arg209His
missense
Exon 8 of 31NP_065873.2Q5JUK3-3
KCNT1
NM_001272003.2
c.482G>Ap.Arg161His
missense
Exon 7 of 31NP_001258932.1Q5JUK3-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.626G>Ap.Arg209His
missense
Exon 8 of 31ENSP00000360822.2Q5JUK3-3
KCNT1
ENST00000460750.5
TSL:1
n.*236G>A
non_coding_transcript_exon
Exon 8 of 32ENSP00000418777.1F8WC49
KCNT1
ENST00000460750.5
TSL:1
n.*236G>A
3_prime_UTR
Exon 8 of 32ENSP00000418777.1F8WC49

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
138936
Hom.:
0
Cov.:
29
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000239
AC:
6
AN:
250854
AF XY:
0.0000368
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000165
AC:
24
AN:
1455600
Hom.:
0
Cov.:
37
AF XY:
0.0000235
AC XY:
17
AN XY:
724054
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33366
American (AMR)
AF:
0.0000225
AC:
1
AN:
44528
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25920
East Asian (EAS)
AF:
0.0000508
AC:
2
AN:
39348
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86202
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51614
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5736
European-Non Finnish (NFE)
AF:
0.00000631
AC:
7
AN:
1108796
Other (OTH)
AF:
0.00
AC:
0
AN:
60090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
138936
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
66422
African (AFR)
AF:
0.00
AC:
0
AN:
36702
American (AMR)
AF:
0.00
AC:
0
AN:
12480
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4654
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4274
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8106
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
282
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66212
Other (OTH)
AF:
0.00
AC:
0
AN:
1906
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000412
AC:
5

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.019
T
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.062
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.55
D
LIST_S2
Uncertain
0.94
D
M_CAP
Pathogenic
0.74
D
MetaRNN
Benign
0.42
T
MetaSVM
Uncertain
0.43
D
MutationAssessor
Benign
1.8
L
PhyloP100
3.2
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.86
N
REVEL
Benign
0.076
Sift
Benign
0.21
T
Sift4G
Benign
0.16
T
Vest4
0.22
MutPred
0.63
Loss of catalytic residue at R176 (P = 0.0657)
MVP
0.85
MPC
0.79
ClinPred
0.40
T
GERP RS
0.68
Varity_R
0.045
gMVP
0.75
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756952430; hg19: chr9-138649027; COSMIC: COSV99705943; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.